Staff Profile
Dr Sally Johnson
Associate Clinical Lecturer
Publications
- Schaefer F, Ardissino G, Ariceta G, Fakhouri F, Scully M, Isbel N, Lommele A, Kupelian V, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Licht C, Vande Walle J, Fremeaux-Bacchi V, Blasco M, Cresseri D, Generolova G, Webb N, Hirt-Minkowski P, Lvovna Kozlovskaya N, Landau D, Lapeyraque A-L, Loirat C, Mache C, Malina M, Martola L, Massart A, Rondeau E, Siedlecki A, Sartz L. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. Kidney International 2018, 94(2), 408-418.
- Walsh PR, Johnson S, Brocklebank V, Salvatore J, Christian M, Kavanagh D. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome. American Journal of Kidney Diseases 2018, 71(2), 287-290.
- Farmery JHR, Smith ML, NIHR BioResource - Rare Diseases, (group includes, Chinnery P, Corris PA, Emmerson I, Horvath R, Johnson S, Shipley D, Wong EKS), Lynch AG. Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data. Scientific Reports 2018, 8, 1300.
- Walsh PR, Johnson S. Treatment and management of children with haemolytic uraemic syndrome. Archives of Disease in Childhood 2018, 103(3), 285-291.
- Brocklebank V, Johnson S, Sheerin TP, Marks SD, Gilbert RD, Tyerman K, Kinoshita M, Awan A, Kaur A, Webb N, Hegde S, Finlay E, Fitzpatrick M, Walsh P, Wong EKS, Booth C, Kerecuk L, Salama A, Almond M, Inward C, Goodship TH, Sheerin N, Marchbank KJ, Kavanagh D. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland. Kidney International 2017, 92(5), Pages 1261-1271.
- Alkanderi S, Yates LM, Johnson SA, Sayer JA. Lessons learned from a multidisciplinary renal genetics clinic. QJM 2017, 110(7), 453-457.
- Sheerin N, Kavanagh D, Goodship THG, Johnson S. A national specialised service in England for atypical haemolytic uraemic syndrome – the first year’s experience. QJM 2016, 109(1), 27-33.
- Montgomery E, Sayer JA, Baines LA, Hynes AM, Vega-Warner V, Johnson S, Goodship JA, Otto EA. Novel compound heterozygous mutations in AMN cause Imerslund-Gräsbeck syndrome in two half-sisters: a case report. BMC Medical Genetics 2015, 16, 35.
- Wong E, Challis R, Sheerin N, Johnson S, Kavanagh D, Goodship TH. Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS). Immunobiology 2015.
- Licht C, Ardissino G, Ariceta G, Cohen D, Cole JA, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Schaefer F, Walle JV, Fremeaux-Bacchi V. The global aHUS registry: Methodology and initial patient characteristics. BMC Nephrology 2015, 16, 207.
- Wong EKS, Marchbank K, Pappworth I, Walters R, Lomax-Browne H, Harris C, Morgan P, Pickering M, Goodship THJ, Malcomson R, Cook T, Johnson S, MPGN C3G Rare Dis Grp. The national study of membranoproliferative glomerulonephrtis and C3 glomerulopathy - characterisation of the paediatric cohort. In: 52nd ERA-EDTA Congress. 2015, London, UK: Oxford University Press.
- Zipfel PF, Skerka C, Chen Q, Wiech T, Goodship T, Johnson S, Fremeaux-Bacchi V, Nester C, de Cordoba SR, Noris M, Pickering M, Smith R. The role of complement in C3 glomerulopathy. Molecular Immunology 2015, 67(1), 21-30.
- Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, Karpman D, Landau D, Langman C, Licht C, Pecoraro C, Riedl M, Siomou E, van de Kar N, Walle JV, Loirat C, Taylor CM. An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatric Nephrology 2014, 29(10), 1967-1978.
- Johnson SA, Wong EKS, Taylor CM. Making sense of the spectrum of glomerular disease associated with complement dysregulation. Pediatric Nephrology 2014, 29(10), 1883-1894.
- Abdel-Salam F, Basu AP, Johnson S, Devlin AM. Suspected pheochromocytoma in a patient with Guillain-Barré syndrome. Pediatrics 2013, 131(3), e955-e958.